Literature DB >> 15493451

Detection of lipid peroxidation in vivo: total hydroxyoctadecadienoic acid and 7-hydroxycholesterol as oxidative stress marker.

Yasukazu Yoshida1, Etsuo Niki.   

Abstract

It is important to assess the oxidative injury in vivo accurately and inclusively, as the oxidative stress induced by various oxidants in a random and destructive fashion is considered to play an important role in the pathophysiology of a number of human disorders and diseases. We have developed an improved method for the measurement of lipid peroxidation in vivo, where total hydroxyoctadecadienoic acids (HODE) and 7-hydroxycholesterol (FCOH) were determined by GC/MS analysis from physiological samples after reduction with sodium borohydride and saponification by potassium hydroxide. In this method, both free and ester forms of hydroperoxides and ketones as well as hydroxides of linoleate and cholesterol are measured as HODE and FCOH, respectively. The ratio of stereo-isomers, (E,E)-HODE/(E,Z)-HODE, could be also measured. The plasma concentrations of total HODE were obtained as 76.5, 666 and 2225 nM for human, rat and mouse, respectively. It was found that HODE and FCOH could be measured satisfactorily by the present method from plasma, erythrocyte and urine of humans and experimental animals. It was also found that HODE in urine arose from both free and ester forms, while 8-iso-prostaglandin F2alpha was present primarily as a free acid form. As the concentrations of HODE were much higher than 8-iso-prostaglandin F2alpha, HODE may well be used as a good oxidative marker in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15493451     DOI: 10.1080/10715760410001700460

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  13 in total

Review 1.  Cholesterol, reactive oxygen species, and the formation of biologically active mediators.

Authors:  Robert C Murphy; Kyle M Johnson
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

2.  Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z,E/E,E stereoisomer ratios.

Authors:  Wei Liu; Huiyong Yin; Yoko Ogawa Akazawa; Yasukazu Yoshida; Etsuo Niki; Ned A Porter
Journal:  Chem Res Toxicol       Date:  2010-05-17       Impact factor: 3.739

3.  Inhibition of serum cholesterol oxidation by dietary vitamin C and selenium intake in high fat fed rats.

Authors:  M Menéndez-Carreño; D Ansorena; F I Milagro; J Campión; J A Martínez; I Astiasarán
Journal:  Lipids       Date:  2008-03-12       Impact factor: 1.880

4.  Combination of TLC blotting and gas chromatography-mass spectrometry for analysis of peroxidized cholesterol.

Authors:  Yuko Minami; Sayuri Yokoi; Mari Setoyama; Noriko Bando; Sayaka Takeda; Yoshichika Kawai; Junji Terao
Journal:  Lipids       Date:  2007-08-15       Impact factor: 1.880

5.  Positive Association between Aqueous Humor Hydroxylinoleate Levels and Intraocular Pressure.

Authors:  Aya Umeno; Yasukazu Yoshida; Sachiko Kaidzu; Masaki Tanito
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

6.  DHA concentration of red blood cells is inversely associated with markers of lipid peroxidation in men taking DHA supplement.

Authors:  Mototada Shichiri; Yuriko Adkins; Noriko Ishida; Aya Umeno; Yasushi Shigeri; Yasukazu Yoshida; Dawn M Fedor; Bruce E Mackey; Darshan S Kelley
Journal:  J Clin Biochem Nutr       Date:  2014-09-09       Impact factor: 3.114

7.  Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo.

Authors:  Yasukazu Yoshida; Aya Umeno; Mototada Shichiri
Journal:  J Clin Biochem Nutr       Date:  2012-12-06       Impact factor: 3.114

8.  Levels of lipid peroxidation in human plasma and erythrocytes: comparison between fatty acids and cholesterol.

Authors:  Yasukazu Yoshida; Yoshiro Saito; Mieko Hayakawa; Yoko Habuchi; Yasuharu Imai; Yoshiyuki Sawai; Etsuo Niki
Journal:  Lipids       Date:  2007-03-15       Impact factor: 1.646

9.  Evaluation of lipophilic antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and isoprostane.

Authors:  Yasukazu Yoshida; Mieko Hayakawa; Yoko Habuchi; Nanako Itoh; Etsuo Niki
Journal:  Lipids       Date:  2007-03-27       Impact factor: 1.646

10.  Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Bjoern Titz; Karsta Luettich; Patrice Leroy; Stephanie Boue; Gregory Vuillaume; Terhi Vihervaara; Kim Ekroos; Florian Martin; Manuel C Peitsch; Julia Hoeng
Journal:  Int J Mol Sci       Date:  2016-09-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.